PetMed Express (NASDAQ:PETS – Get Free Report) will likely be announcing its Q1 2027 results after the market closes on Thursday, August 13th. Analysts expect PetMed Express to announce earnings of $0.12 per share and revenue of $71.00 million for the quarter. Investors may review the information on the company’s upcoming Q1 2027 earning report page for the latest details on the call scheduled for Thursday, August 13, 2026 at 4:30 PM ET.
PetMed Express (NASDAQ:PETS – Get Free Report) last issued its quarterly earnings results on Tuesday, June 2nd. The company reported ($0.19) EPS for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.01). The business had revenue of $42.82 million for the quarter, compared to analysts’ expectations of $52.00 million. PetMed Express had a negative net margin of 32.00% and a negative return on equity of 76.86%. During the same period in the previous year, the business posted ($0.56) earnings per share. On average, analysts expect PetMed Express to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
PetMed Express Trading Up 0.5%
Shares of PetMed Express stock opened at $1.98 on Wednesday. The business’s fifty day simple moving average is $1.90 and its 200 day simple moving average is $2.32. PetMed Express has a 12 month low of $1.57 and a 12 month high of $4.10. The firm has a market capitalization of $42.31 million, a P/E ratio of -0.72 and a beta of 0.76.
Analyst Upgrades and Downgrades
View Our Latest Stock Report on PetMed Express
Hedge Funds Weigh In On PetMed Express
Large investors have recently modified their holdings of the business. Bridgeway Capital Management LLC grew its stake in PetMed Express by 17.2% in the 4th quarter. Bridgeway Capital Management LLC now owns 126,351 shares of the company’s stock valued at $404,000 after buying an additional 18,535 shares in the last quarter. UMB Bank n.a. bought a new position in PetMed Express in the 4th quarter worth about $192,000. State Street Corp raised its stake in PetMed Express by 7.8% in the fourth quarter. State Street Corp now owns 105,173 shares of the company’s stock valued at $337,000 after purchasing an additional 7,600 shares in the last quarter. Empowered Funds LLC raised its position in shares of PetMed Express by 14.2% during the 4th quarter. Empowered Funds LLC now owns 68,651 shares of the company’s stock valued at $220,000 after buying an additional 8,535 shares in the last quarter. Finally, CIBC Bancorp USA Inc. purchased a new stake in PetMed Express during the third quarter valued at about $153,000. Hedge funds and other institutional investors own 73.33% of the company’s stock.
About PetMed Express
PetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.
Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.
Featured Stories
- Five stocks we like better than PetMed Express
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.
